Luis Antonio Diaz

机构：Pontificia Universidad Católica de Chile, UC San Diego Health System, University of California San Diego, University of California San Diego Medical Center, Indiana University – Purdue University Indianapolis · ORCID：0000-0002-8540-4930

发表论文 70 篇 · 总被引 742 次 · h-index 10

代表论文

• Subtype Differences in Major Adverse Liver Outcomes and Cardiovascular Events and Mortality in Steatotic Liver Disease: A UK Biobank Analysis (2026 · Alimentary Pharmacology & Therapeutics · 被引 3)
• Letter on ‘Network Meta‐Analysis: Comparison of Pharmacological Therapies in Compensated MASH Cirrhosis for Fibrosis Regression and MASH Resolution’ (2026 · Alimentary Pharmacology & Therapeutics · 被引 1)
• Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALD (2026 · Hepatology Communications)
• Hepatitis C among people experiencing homelessness in Chile: prevalence and associated factors. (2026 · PubMed)
• Liver donor macrosteatosis is associated with adverse long-term outcomes exclusively in metabolic dysfunction-associated steatotic liver disease recipients: a U.S. transplant registry analysis over the last decade (2026 · HepatoBiliary Surgery and Nutrition)
• Epidemiology of Alcohol-Associated Hepatitis: A Systematic Review of Population-Based Studies (2026 · Clinical Gastroenterology and Hepatology)